Current Investments
Our investment portfolio includes these selected examples. Original underwriting dates shown, with dollar amounts rounded to nearest million.
Current Investments
Advanced Oxygen Therapy
03.21.22
$12.0 million
Structured Credit
Best ABT
11.12.18
$5.8 million
Royalty Reorganization
BIOLASE
11.09.18
$15.0 million
Structured Credit
Biotricity
12.27.21
$12.0 million
Structured Credit
Cambia
07.31.14
$9.5 million
Royalty Acquisition
Coflex
08.31.20
$4.4 million
Royalty Portfolio Acquisition
Secured Royalty Financing for Pharmaceutical Product
Women’s Health
06.07.13
$3.1 million
Royalty Financing
Elutia
08.10.22
$25.0 million
Structured Credit
Exeevo
07.01.22
$7.5 million
Structured Credit
Eton Pharmaceuticals
11.14.19
$10.0 million
Structured Credit
Flowonix Medical
12.23.20
$10.0 million
Structured Credit
ForFivo (IntelGenx)
08.05.16
$6.0 million
Royalty Acquisition
4WEB Medical
06.03.19
$20.0 million
Structured Credit
Ideal Implant
04.27.21
$5.0 million
Synthetic Royalty Financing
Iluvien
12.18.20
$16.5 million
Royalty Acquisition
Private Transaction
Immune Globulin Portfolio
12.27.2023
$14.1 million
Royalty Acquisition
Journey Medical Corporation
12.27.2023
$20.0 million
Structured Credit
Kybella
08.31.20
$4.4 million
Royalty Portfolio Acquisition
MedMinder Systems
08.18.22
$25.0 million
Structured Credit
MolecuLight
01.04.22
$10.0 million
Structured Credit
NeoLight
02.17.23
$5.0 million
Structured Credit
Nicoya
10.19.23
$6.0 million
Structured Credit
Secured Royalty Financing for Pharmaceutical Product
Project Duo Royalty
11.30.22
$16.5 million
Royalty Acquisition
Relief Therapeutics
08.02.2024
$11.0 million
Royalty Portfolio Acquisition
Shield Therapeutics
10.19.23
$20.0 million
Structured Credit
Sincerus Pharmaceuticals
03.19.21
$12.3 million
Structured Credit
Sponsor-backed CDMO
09.13.23
$5 million
Structured Credit
Trio Healthcare
07.01.21
$9.5 million
Structured Credit
Triple Ring Technologies
12.06.24
$8.0 million
Structured Credit
Veru
03.05.18
$12.0 million
Synthetic Royalty Financing